Article

Timing of antiretroviral therapy for HIV-infected patients with moderate-to-severe Pneumocystis pneumonia: study protocol for a multi-center prospective randomized controlled trial

2020-03-25

Abstract excerpt

<h4>Background: </h4> Pneumocystis pneumonia (PCP) is a common AIDS-related opportunistic infection. Recent reports estimate that more than 400,000 HIV patients develop PCP each year globally. However, the timing of antiretroviral therapy (ART) initiation for HIV infected patients with PCP is still controversial, and the benefits and risks of early initiation of ART are not completely clear. We thus designed this...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 5aa859b8-46fe-5a94-9b73-a0e7088726a0
DOI: 10.21203/rs.3.rs-19306/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Timing of antiretroviral therapy for HIV-infected patients with moderate-to-severe Pneumocystis pneumonia: study protocol for a multi-center prospective randomized controlled trialDOI 10.21203/rs.3.rs-19306/v1Read

Timing of Antiretroviral Therapy for HIV-Infected Patients with Cytomegalovirus Retinitis: Study Protocol of a Multi-Center Prospective Randomized Controlled TrialSemantic proximity Read

HIV-associated Pneumocystis pneumonia.Semantic proximity Read

IRIS and Mortality in Advanced HIV: Post-Pandemic Experience from a Single-Center Case SeriesSemantic proximity Read

Association Between ART Initiation Timing and Treatment Outcomes in Older People Living With HIV: A Longitudinal Study from Baise, ChinaSemantic proximity Read

Empirical Treatment Against Cytomegalovirus and Tuberculosis in HIV-Infected Infants with Severe Pneumonia: Study Protocol for a Multicenter, an Open-Label Randomized Controlled Clinical TrialSemantic proximity Read

<i>Pneumocystis jirovecii</i>pneumonia mortality risk associated with preceding long-term steroid use for the underlying disease: a multicenter, retrospective cohort studySemantic proximity Read

Treatment of Pneumocystis jirovecii pneumonia in HIV-infected patients: a review.Semantic proximity Read

Same-day testing with initiation of antiretroviral therapy or tuberculosis treatment versus standard care for persons presenting with tuberculosis symptoms at HIV diagnosis: A randomized unblinded trialSemantic proximity Read

The characteristics of HIV-positive patients with mild/asymptomatic and moderate/severe course of COVID-19 disease – a report from Central and Eastern EuropeSemantic proximity Read

Oral Pre-exposure prophylaxis (PrEP) to prevent HIV: a systematic review and meta-analysis of clinical effectiveness, safety, adherence and risk compensation in all populationsSemantic proximity Read

Outcomes of the three-month weekly isoniazid with rifapentine (3HP) versus the six-month isoniazid preventive therapy (6H) among people newly enrolled in HIV care in western KenyaSemantic proximity Read

Early intervention with 3BNC117 and romidepsin at antiretroviral treatment initiation in people with HIV-1: a phase 1b/2a, randomized trialSemantic proximity Read